COVID-19 AND HIV: CLINICIAN SURVEY
RequiredRequired Question(s)

COVID-19 has had a profound impact on health systems and their ability to deliver critical services for chronic health conditions, including HIV. IAPAC is gauging the effects local COVID-19's responses are having on the delivery of HIV services.


If you are a clinician who treats people living with or at-risk for HIV, please complete our 10-question survey. Your input will inform our efforts to facilitate forward momentum in the global HIV response. Thank you for your assistance!

 
Required 1.

Are you a clinician who treats people living with or at-risk for HIV? 

Yes
No
2.

In which country do you primarily practice medicine? 


Country:

3.

Do your clinical duties now include managing patients with SARS-CoV-2 infection?

Yes
No
4.

In your clinical setting, have there been disruptions in any of the following HIV services attributable to the COVID-19 response in your community? (Select all that apply.) 

HIV antibody testing
Antiretroviral initiation
Laboratory monitoring of antiretroviral therapy (i.e., viral load testing)
Laboratory monitoring for sexually transmitted infections
HIV case management
Post-exposure prophylaxis (PEP) initiation
Pre-exposure prophylaxis (PrEP) initiation
Sexual/reproductive health
Mental and psychosocial health
Substance use (e.g., harm reduction, treatment)
5.

How concerned are you about the ability of your HIV-positive patients to maintain optimal adherence to antiretroviral therapy (ART) in the midst of your community's COVID-19 epidemic?

Not concerned Moderately concerned Very concerned         
        
6.

How concerned are you about your HIV-negative patients' access to pre-exposure prophylaxis (PrEP) and/or post-exposure prophylaxis (PEP) in the midst of your community's COVID-19 epidemic?

Not concerned Moderately concerned Very concerned         
        
7.

How concerned are you about your patients' ability to access mental health services in the midst of your community's COVID-19 epidemic?

Not concerned Moderately concerned Very concerned         
        
8.

How concerned are you that sexual and other risk-taking (i.e., substance use) is increasing in the midst of your community's COVID-19 epidemic? 

Not concerned Moderately concerned Very concerned         
        
9.

How concerned are you about racial disparities in COVID-19 clinical outcomes, including mortality, in your community?

Not concerned Moderately concerned Very concerned         
        
10.

In your opinion, after the initial "peak" of COVID-19 hospitalizations and deaths, how long will it take for your community to restore at least the same standard of care for people living with and at-risk for HIV that existed before the first reported cases of COVID-19? 

Less than one year
Between one to three years
Between three to five years
More than five years
Standard of care remains unchanged